Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 39

1.

Exosite 1 thrombin inhibition with JNJ-64179375 inhibits thrombus formation in a human translational model of thrombosis.

Wilson SJ, Connolly TM, Peters G, Ghosh A, Johnson M, Newby DE.

Cardiovasc Res. 2019 Mar 1;115(3):669-677. doi: 10.1093/cvr/cvy227.

2.

LC-MS/MS quantification of 7α-hydroxy-4-cholesten-3-one (C4) in rat and monkey plasma.

Kang L, Connolly TM, Weng N, Jian W.

J Chromatogr B Analyt Technol Biomed Life Sci. 2017 Oct 1;1064:49-55. doi: 10.1016/j.jchromb.2017.09.006. Epub 2017 Sep 5.

PMID:
28915417
3.

Longitudinal clinical findings and outcome among patients with Cryptococcus gattii infection in British Columbia.

Phillips P, Galanis E, MacDougall L, Chong MY, Balshaw R, Cook VJ, Bowie W, Steiner T, Hoang L, Morshed M, Ghesquiere W, Forrest DM, Roscoe D, Doyle P, Kibsey PC, Connolly T, Mirzanejad Y, Thompson D; British Columbia Cryptococcus gattii Study Group.

Clin Infect Dis. 2015 May 1;60(9):1368-76. doi: 10.1093/cid/civ041. Epub 2015 Jan 28.

PMID:
25632012
4.

A normative study of the sport concussion assessment tool (SCAT2) in children and adolescents.

Snyder AR, Bauer RM; Health IMPACTS for Florida Network.

Clin Neuropsychol. 2014;28(7):1091-103. doi: 10.1080/13854046.2014.952667. Epub 2014 Sep 22.

5.

Effect of PSI-697, a novel P-selectin inhibitor, on platelet-monocyte aggregate formation in humans.

Japp AG, Chelliah R, Tattersall L, Lang NN, Meng X, Weisel K, Katz A, Burt D, Fox KA, Feuerstein GZ, Connolly TM, Newby DE.

J Am Heart Assoc. 2013 Jan 28;2(1):e006007. doi: 10.1161/JAHA.112.006007.

6.

Progress in ion torrent semiconductor chip based sequencing.

Merriman B; Ion Torrent R&D Team, Rothberg JM.

Electrophoresis. 2012 Dec;33(23):3397-417. doi: 10.1002/elps.201200424. Review. Erratum in: Electrophoresis. 2013 Feb;34(4):619.

PMID:
23208921
7.

Clovis age Western Stemmed projectile points and human coprolites at the Paisley Caves.

Jenkins DL, Davis LG, Stafford TW Jr, Campos PF, Hockett B, Jones GT, Cummings LS, Yost C, Connolly TJ, Yohe RM 2nd, Gibbons SC, Raghavan M, Rasmussen M, Paijmans JL, Hofreiter M, Kemp BM, Barta JL, Monroe C, Gilbert MT, Willerslev E.

Science. 2012 Jul 13;337(6091):223-8. doi: 10.1126/science.1218443.

8.

In vivo mononuclear cell tracking using superparamagnetic particles of iron oxide: feasibility and safety in humans.

Richards JM, Shaw CA, Lang NN, Williams MC, Semple SI, MacGillivray TJ, Gray C, Crawford JH, Alam SR, Atkinson AP, Forrest EK, Bienek C, Mills NL, Burdess A, Dhaliwal K, Simpson AJ, Wallace WA, Hill AT, Roddie PH, McKillop G, Connolly TA, Feuerstein GZ, Barclay GR, Turner ML, Newby DE.

Circ Cardiovasc Imaging. 2012 Jul;5(4):509-17. doi: 10.1161/CIRCIMAGING.112.972596. Epub 2012 Jul 10.

PMID:
22787016
9.

Synergistic effect of liver X receptor activation and simvastatin on plaque regression and stabilization: an magnetic resonance imaging study in a model of advanced atherosclerosis.

Giannarelli C, Cimmino G, Connolly TM, Ibanez B, Ruiz JM, Alique M, Zafar MU, Fuster V, Feuerstein G, Badimon JJ.

Eur Heart J. 2012 Jan;33(2):264-73. doi: 10.1093/eurheartj/ehr136. Epub 2011 May 23.

PMID:
21606082
10.

Characterisation and reproducibility of a human ex vivo model of thrombosis.

Lucking AJ, Chelliah R, Trotman AD, Connolly TM, Feuerstein GZ, Fox KA, Boon NA, Badimon JJ, Newby DE.

Thromb Res. 2010 Nov;126(5):431-5. doi: 10.1016/j.thromres.2010.06.030. Epub 2010 Aug 25.

PMID:
20800267
11.

Biomarkers of vulnerable atheromatous plaques: translational medicine perspectives.

Wang X, Connolly TM.

Adv Clin Chem. 2010;50:1-22. Review.

PMID:
20521438
12.

Carbon-nanotube-polymer nanocomposites for field-emission cathodes.

Connolly T, Smith RC, Hernandez Y, Gun'ko Y, Coleman JN, Carey JD.

Small. 2009 Apr;5(7):826-31. doi: 10.1002/smll.200801094.

PMID:
19199333
13.

Mobilisation of Ca2+ stores and flagellar regulation in human sperm by S-nitrosylation: a role for NO synthesised in the female reproductive tract.

Machado-Oliveira G, Lefièvre L, Ford C, Herrero MB, Barratt C, Connolly TJ, Nash K, Morales-Garcia A, Kirkman-Brown J, Publicover S.

Development. 2008 Nov;135(22):3677-86. doi: 10.1242/dev.024521. Epub 2008 Oct 8.

14.

Discovery of 1,4-substituted piperidines as potent and selective inhibitors of T-type calcium channels.

Yang ZQ, Barrow JC, Shipe WD, Schlegel KA, Shu Y, Yang FV, Lindsley CW, Rittle KE, Bock MG, Hartman GD, Uebele VN, Nuss CE, Fox SV, Kraus RL, Doran SM, Connolly TM, Tang C, Ballard JE, Kuo Y, Adarayan ED, Prueksaritanont T, Zrada MM, Marino MJ, Graufelds VK, DiLella AG, Reynolds IJ, Vargas HM, Bunting PB, Woltmann RF, Magee MM, Koblan KS, Renger JJ.

J Med Chem. 2008 Oct 23;51(20):6471-7. doi: 10.1021/jm800830n. Epub 2008 Sep 26.

PMID:
18817368
15.

Documenting clinical encounters: a recipe for success.

Connolly T.

Menopause. 2008 Sep-Oct;15(5):830-1. doi: 10.1097/gme.0b013e318182d377. No abstract available.

PMID:
18779675
16.

Design, synthesis, and evaluation of a novel 4-aminomethyl-4-fluoropiperidine as a T-type Ca2+ channel antagonist.

Shipe WD, Barrow JC, Yang ZQ, Lindsley CW, Yang FV, Schlegel KA, Shu Y, Rittle KE, Bock MG, Hartman GD, Tang C, Ballard JE, Kuo Y, Adarayan ED, Prueksaritanont T, Zrada MM, Uebele VN, Nuss CE, Connolly TM, Doran SM, Fox SV, Kraus RL, Marino MJ, Graufelds VK, Vargas HM, Bunting PB, Hasbun-Manning M, Evans RM, Koblan KS, Renger JJ.

J Med Chem. 2008 Jul 10;51(13):3692-5. doi: 10.1021/jm800419w. Epub 2008 Jun 10.

PMID:
18540666
17.

Pericoronitis as an initial manifestation of acute lymphoblastic leukemia: a case report.

Aronovich S, Connolly TW.

J Oral Maxillofac Surg. 2008 Apr;66(4):804-8. doi: 10.1016/j.joms.2006.10.062. No abstract available.

PMID:
18355610
18.

Tetrabromobisphenol A (TBBPA), induces cell death in TM4 Sertoli cells by modulating Ca2+ transport proteins and causing dysregulation of Ca2+ homeostasis.

Ogunbayo OA, Lai PF, Connolly TJ, Michelangeli F.

Toxicol In Vitro. 2008 Jun;22(4):943-52. doi: 10.1016/j.tiv.2008.01.015. Epub 2008 Feb 5.

PMID:
18329244
19.

Nuclear receptors as drug targets in obesity, dyslipidemia and atherosclerosis.

Hansen MK, Connolly TM.

Curr Opin Investig Drugs. 2008 Mar;9(3):247-55. Review.

PMID:
18311660
20.

Cyclic benzamidines as orally efficacious NR2B-selective NMDA receptor antagonists.

Nguyen KT, Claiborne CF, McCauley JA, Libby BE, Claremon DA, Bednar RA, Mosser SD, Gaul SL, Connolly TM, Condra CL, Bednar B, Stump GL, Lynch JJ, Koblan KS, Liverton NJ.

Bioorg Med Chem Lett. 2007 Jul 15;17(14):3997-4000. Epub 2007 Apr 29.

PMID:
17498948

Supplemental Content

Loading ...
Support Center